References
Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM (1999) Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 29:361–366
Mondy KE, Shannon W, Mundy LM (2001) Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 33:473–476
Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R (1996) Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 173:1129–1136
Salgado CD, Giannetta ET, Farr BM (2014) Failure to develop vancomycin-resistant enterococcus with oral vancomycin treatment of Clostridium difficile. Infect Control Hosp Epidemiol 25:413–417
Al-Nassir WN, Sethi AK, Li Y, Pultz MJ, Riggs MM, Donskey CJ (2008) Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 52:2403–2406
Conflicts of interest
The authors have no potential conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van Prehn, J., Stemerding, A.M., Van Saene, H.K.F. et al. Oral vancomycin might be useful to suppress enteral VRE load: a conceptual experiment. Intensive Care Med 40, 1171–1172 (2014). https://doi.org/10.1007/s00134-014-3365-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-014-3365-x